Description:

PLUS is the ticker symbol for Plus Therapeutics, Inc., a biopharmaceutical company listed on the New York Stock Exchange (NYSE). The company focuses on the development and commercialization of innovative therapies for the treatment of cancer. Its lead product candidate, which is currently in clinical trials, aims to address unmet medical needs in the oncology field by offering more effective and less toxic alternatives to existing treatments. Investors interested in biotech and pharmaceutical innovations may find Plus Therapeutics an intriguing option within the NYSE marketplace.

Data:

Yields: